Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention
- 1 May 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 87 (10) , 1231-1233
- https://doi.org/10.1016/s0002-9149(01)01506-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- In vivo demonstration of an antithrombin effect of abciximabThe American Journal of Cardiology, 2000
- Antithrombotic effects of AbciximabThe American Journal of Cardiology, 2000
- Rapid Platelet-Function AssayCirculation, 1999
- Glycoprotein IIb/IIIa Receptor Antagonist Tirofiban Inhibits Thrombin Generation during Cardiopulmonary Bypass in BaboonsThrombosis and Haemostasis, 1999
- Administration of Abciximab During Percutaneous Coronary Intervention Reduces Both Ex Vivo Platelet Thrombus Formation and Fibrin DepositionArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Networking in the Hemostatic SystemJournal of Biological Chemistry, 1997
- Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary AngioplastyCirculation, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE studyThe Lancet, 1997
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Journal of Clinical Investigation, 1996